π
Business / Licensing β The theranostics market is growing rapidly, creating demand for safe and scalable solutions to deliver next-generation radiopharmaceuticals. Our patented process provides a proven framework for radioactive drug handling, with applications across leading isotopes including zirconium-89 (Zr-89), lead-212 (Pb-212), lutetium-177 (Lu-177), and actinium-225 (Ac-225).
Contact information
Contact details available on Pro plan β phone
Business details
CountryπΊπΈ US
CategorySaaS
PlatformWordPress